Targeting IFNalpha to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance.

Liang Y, Tang H, Guo J, Qiu X, Yang Z, Ren Z, Sun Z, Bian Y, Xu L, Xu H, Shen J, Han Y, Dong H, Peng H, Fu YX
Nat Commun. 2018 Nov 2;9(1):4586. doi: 10.1038/s41467-018-06890-y. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.